As of November 6, 2026, RxSight, Inc. is a publicly traded company (Nasdaq: RXST); its largest reported holder is BlackRock, with 8.4% on Schedule 13G/A of October 27, 2026, then BlackRock (6.9%). The largest insider holding is Ronald M. Kurtz MD, the chief medical officer, with 836,385 shares (2.0% of shares outstanding), per Form 4 of September 2, 2026 (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in RxSight, Inc.? See the free Snapshot first.
Free to see. No signup.
Is RxSight, Inc. a real, registered company?
- RxSight, Inc. files with the SEC under CIK 1111485 (its SEC filings).
- Its shares are listed under the ticker RXST on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Aliso Viejo, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under RxSight, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Aziz Mottiwala, President and Chief Executive Officer (Form 8-K filed 2026-07-15). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Millennium (filed 2026-11-02).
Who are RxSight, Inc.'s owners and officers?
RxSight, Inc.: incorporated in Delaware; business address in Aliso Viejo, California; industry Ophthalmic Goods (Schedule 13G/A, 2026-11-02).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-02 | Millennium Management LLC | 5.1% |
| Schedule 13G/A, 2026-10-27 | Blackrock Portfolio Management LLC | 8.4% |
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 6.9% |
| Schedule 13G, 2026-08-19 | Point72 Asset Management, L.P. | 6% |
| Schedule 13G/A, 2026-08-04 | Millennium Management LLC | 7.3% |
| Schedule 13G, 2026-07-17 | Blackrock Portfolio Management LLC | 7.2% |
| Schedule 13G/A, 2026-05-13 | Artisan Partners Asset Management Inc. | 5% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-03 | Artisan Partners Asset Management Inc. | 5.2% |
| Schedule 13G/A, 2025-11-14 | Ra Capital Management, L.P. | 0% |
| Schedule 13G/A, 2025-11-12 | Artisan Partners Asset Management Inc. | 4.3% |
| Schedule 13G/A, 2025-11-04 | Millennium Management LLC | 5.4% |
Questions about who owns RxSight, Inc.
Who owns RxSight, Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of RxSight, Inc.: Blackrock Portfolio Management LLC (8.4%, Schedule 13G/A, filed 2026-10-27), Blackrock, Inc. (6.9%, Schedule 13G/A, filed 2026-10-27), Point72 Asset Management, L.P. (6%, Schedule 13G, filed 2026-08-19), Millennium Management LLC (5.1%, Schedule 13G/A, filed 2026-11-02) and Artisan Partners Asset Management Inc. (5%, Schedule 13G/A, filed 2026-05-13).
Who are the largest shareholders of RxSight, Inc.?
By the share each holder's latest filing reports, the largest holders of RxSight, Inc. on this page are Blackrock Portfolio Management LLC (8.4%), Blackrock, Inc. (6.9%) and Point72 Asset Management, L.P. (6%).
When did Blackrock Portfolio Management LLC buy into RxSight, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock Portfolio Management LLC on this page is the Schedule 13G, filed 2026-07-17, reporting 7.2%; its latest, Schedule 13G/A filed 2026-10-27, reports 8.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on RxSight, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on RxSight, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RxSight, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-15 | Aziz Mottiwala | President and Chief Executive Officer | appointed | |
| Form 8-K, 2026-07-15 | Aziz Mottiwala | appointed |
Which insiders own RxSight, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief medical officer: 836,385 shares (2.0% of shares outstanding), 71,775 held directly and 764,610 indirectly (Form 4, 2026-09-02).
- Eric Weinberg: 536,419 shares (1.3% of shares outstanding), 235,516 held directly and 300,903 indirectly (Form 4, 2026-09-16).
- , a director: 108,145 shares (0.26% of shares outstanding), 86,227 held directly and 21,918 indirectly (Form 4, 2026-06-18).
- , a director: 96,140 shares (0.23% of shares outstanding), 74,892 held directly and 21,248 indirectly (Form 4, 2026-06-18).
- , a director: 86,731 shares (0.21% of shares outstanding), 85,183 held directly and 1,548 indirectly (Form 4, 2026-06-18).
Shares outstanding: 41,929,222 as of 2026-10-30, from the company's latest SEC cover page.
How much has RxSight, Inc. raised?
No fundraising or offering filing from RxSight, Inc. is on file with us.
Keep reading
More on RxSight, Inc. and the records around it.
RxSight, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Leadership changes Jul 2026
Companies that share a holder
- Artisan Partners Asset Management Inc. also filed stake reports on 16 other companies: Ascendis Pharma A/S (Aug 2026), AXALTA COATING SYSTEMS LTD. (Aug 2026), iRhythm Holdings, Inc. (Aug 2026)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026), PIMCO MUNICIPAL INCOME FUND II (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/rxsight